中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2014年
16期
2473-2474,2475
,共3页
陈莉%郭丽银%王利%张文静%王红祥
陳莉%郭麗銀%王利%張文靜%王紅祥
진리%곽려은%왕리%장문정%왕홍상
集落刺激因子%T淋巴细胞亚群%白血病,髓样
集落刺激因子%T淋巴細胞亞群%白血病,髓樣
집락자격인자%T림파세포아군%백혈병,수양
Colony-stimulating factors%T-lymphocyte subsets%Leukemia,myeloid
目的:研究粒系集落刺激因子( G-CSF )和粒单系集落刺激因子( GM-CSF )对完全缓解急性髓系白血病( AML)患者树突状细胞( DC)的功能及其亚群变化。方法将36例化疗达完全缓解的AML患者根据随机数字表法分为三组,G组给予G-CSF 200μg/d皮下注射,GM组给予GM-CSF 200μg/d皮下注射,对照组( C组)皮下注射0.9%氯化钠注射液。比较其疗效。结果 G组DC表面CD80、CD83和CD86表达均低于GM组和C组(t=4.34、5.43、4.54、4.54、5.25、3.54,均P<0.05),GM组DC表达CD11c高于G组和C组(t=4.54、4.27,均P<0.05)。 G组和GM组DC促淋巴细胞增殖能力均高于C组(t=4.54、5.64,均P<0.05);GM组DC促进CD4+T淋巴细胞增殖的能力高于G组(t=3.54,P<0.05)。 ELISA法检测发现,GM组DC分泌IL-12高于G组和C组;G组DC分泌IL-10高于GM组和C组( t=3.54、4.23、4.32、3.87,均P<0.05)。结论 G-CSF和GM-CSF可使完全缓解AML患者DC亚群发生偏移,G-CSF促使其偏向DC2而具有一定免疫抑制作用,而GM-CSF使DC亚群偏向DC1而促进细胞免疫。
目的:研究粒繫集落刺激因子( G-CSF )和粒單繫集落刺激因子( GM-CSF )對完全緩解急性髓繫白血病( AML)患者樹突狀細胞( DC)的功能及其亞群變化。方法將36例化療達完全緩解的AML患者根據隨機數字錶法分為三組,G組給予G-CSF 200μg/d皮下註射,GM組給予GM-CSF 200μg/d皮下註射,對照組( C組)皮下註射0.9%氯化鈉註射液。比較其療效。結果 G組DC錶麵CD80、CD83和CD86錶達均低于GM組和C組(t=4.34、5.43、4.54、4.54、5.25、3.54,均P<0.05),GM組DC錶達CD11c高于G組和C組(t=4.54、4.27,均P<0.05)。 G組和GM組DC促淋巴細胞增殖能力均高于C組(t=4.54、5.64,均P<0.05);GM組DC促進CD4+T淋巴細胞增殖的能力高于G組(t=3.54,P<0.05)。 ELISA法檢測髮現,GM組DC分泌IL-12高于G組和C組;G組DC分泌IL-10高于GM組和C組( t=3.54、4.23、4.32、3.87,均P<0.05)。結論 G-CSF和GM-CSF可使完全緩解AML患者DC亞群髮生偏移,G-CSF促使其偏嚮DC2而具有一定免疫抑製作用,而GM-CSF使DC亞群偏嚮DC1而促進細胞免疫。
목적:연구립계집락자격인자( G-CSF )화립단계집락자격인자( GM-CSF )대완전완해급성수계백혈병( AML)환자수돌상세포( DC)적공능급기아군변화。방법장36례화료체완전완해적AML환자근거수궤수자표법분위삼조,G조급여G-CSF 200μg/d피하주사,GM조급여GM-CSF 200μg/d피하주사,대조조( C조)피하주사0.9%록화납주사액。비교기료효。결과 G조DC표면CD80、CD83화CD86표체균저우GM조화C조(t=4.34、5.43、4.54、4.54、5.25、3.54,균P<0.05),GM조DC표체CD11c고우G조화C조(t=4.54、4.27,균P<0.05)。 G조화GM조DC촉림파세포증식능력균고우C조(t=4.54、5.64,균P<0.05);GM조DC촉진CD4+T림파세포증식적능력고우G조(t=3.54,P<0.05)。 ELISA법검측발현,GM조DC분비IL-12고우G조화C조;G조DC분비IL-10고우GM조화C조( t=3.54、4.23、4.32、3.87,균P<0.05)。결론 G-CSF화GM-CSF가사완전완해AML환자DC아군발생편이,G-CSF촉사기편향DC2이구유일정면역억제작용,이GM-CSF사DC아군편향DC1이촉진세포면역。
Objective To study the granulocyte colony stimulating factor ( G-CSF ) and granulocyte macro-phage colony stimulating factor ( GM-CSF) in complete remission of acute myeloid leukemia ( AML) patients with den-dritic cells(DC)changes in the function and its subsets .Methods 36 cases of complete remission according to AML patients were randomly divided into 3 groups,G group was given G-CSF 200g/d,subcutaneous injection ,GM group were given GM-CSF 200g/d,subcutaneous injection ,the control group were injected with normal saline .The curative effects were compared.Results The expression of G in group DC,CD83 and CD86 on surface of CD80 were lower than that in GM group and C group (t=4.34,5.43,4.54,4.54,5.25,3.54,all P<0.05),GM group,DC expression of CD11c was higher than that of G group and C group (t=4.54,4.27,all P<0.05).G group and GM group DC in promoting lymphocyte proliferation were higher than those in C group (t=4.54,5.64,all P<0.05);group GM DC to promote the ability of CD4 +T lymphocyte proliferation was higher than that of G group (t=3.54,P<0.05).ELISA assay,GM group DC secretion of IL-12 than that of group G and C group;group G DC secretion of IL-10 was higher than that of GM group and C group (t=3.54.4.23,4.32,3.87,all P<0.05).Conclusion G-CSF and GM-CSF can make the complete remission in patients with AML subgroup DC shift ,the bias of G-CSF DC2 and certain immuno-suppressive effect ,while GM-CSF DC subsets of DC 1 and promotes cell immune deviation .